Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.

Delcore R, Rodriguez FJ, Forster J, Hermreck AS, Thomas JH.

Am J Surg. 1996 Nov;172(5):463-8; discussion 468-9.

PMID:
8942545
2.

Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.

Benassai G, Mastrorilli M, Mosella F, Mosella G.

J Exp Clin Cancer Res. 1999 Mar;18(1):23-8.

PMID:
10374672
3.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2.

PMID:
19418101
4.

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.

Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.

PMID:
18376190
5.

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.

Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA.

Surgery. 2007 May;141(5):610-8.

PMID:
17462460
6.

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.

Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.

Ann Surg Oncol. 2008 Jan;15(1):165-74.

PMID:
17896141
8.
9.

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

Nitecki SS, Sarr MG, Colby TV, van Heerden JA.

Ann Surg. 1995 Jan;221(1):59-66.

10.

Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas.

Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Forestieri P, Mazzeo F.

J Surg Oncol. 2000 Apr;73(4):212-8.

PMID:
10797334
11.
12.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

13.

Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.

Pai RK, Beck AH, Mitchem J, Linehan DC, Chang DT, Norton JA, Pai RK.

Am J Surg Pathol. 2011 Feb;35(2):228-34. doi: 10.1097/PAS.0b013e318206c37a.

PMID:
21263243
14.

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.

Fortner JG, Klimstra DS, Senie RT, Maclean BJ.

Ann Surg. 1996 Feb;223(2):147-53.

15.

Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.

Meriggi F, Gramigna P, Forni E.

Hepatogastroenterology. 2007 Mar;54(74):549-55.

PMID:
17523320
16.

Pancreatic resection for M1 pancreatic ductal adenocarcinoma.

Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Büchler MW.

Ann Surg Oncol. 2007 Jan;14(1):118-27.

PMID:
17066229
17.

Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer.

House MG, Gönen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y, Brennan MF, Allen PJ.

J Gastrointest Surg. 2007 Nov;11(11):1549-55.

PMID:
17786531
18.

Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Falconi M, Crippa S, Domínguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P.

Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4.

PMID:
18712568
19.

Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Zacharias T, Jaeck D, Oussoultzoglou E, Neuville A, Bachellier P.

J Gastrointest Surg. 2007 Mar;11(3):350-6.

PMID:
17458610
20.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
Items per page

Supplemental Content

Support Center